4-88008094-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_000297.4(PKD2):​c.361G>T​(p.Gly121Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000106 in 1,517,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

PKD2
NM_000297.4 missense

Scores

2
5
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 5.76

Publications

1 publications found
Variant links:
Genes affected
PKD2 (HGNC:9009): (polycystin 2, transient receptor potential cation channel) This gene encodes a member of the polycystin protein family. The encoded protein is a multi-pass membrane protein that functions as a calcium permeable cation channel, and is involved in calcium transport and calcium signaling in renal epithelial cells. This protein interacts with polycystin 1, and they may be partners in a common signaling cascade involved in tubular morphogenesis. Mutations in this gene are associated with autosomal dominant polycystic kidney disease type 2. [provided by RefSeq, Mar 2011]
PKD2 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • polycystic kidney disease 2
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01305005).
BP6
Variant 4-88008094-G-T is Benign according to our data. Variant chr4-88008094-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 434012.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000988 (15/151794) while in subpopulation SAS AF = 0.00145 (7/4832). AF 95% confidence interval is 0.000679. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000297.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKD2
NM_000297.4
MANE Select
c.361G>Tp.Gly121Cys
missense
Exon 1 of 15NP_000288.1
PKD2
NM_001440544.1
c.361G>Tp.Gly121Cys
missense
Exon 1 of 14NP_001427473.1
PKD2
NR_156488.2
n.460G>T
non_coding_transcript_exon
Exon 1 of 14

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKD2
ENST00000237596.7
TSL:1 MANE Select
c.361G>Tp.Gly121Cys
missense
Exon 1 of 15ENSP00000237596.2
ENSG00000286618
ENST00000662475.1
n.112+272C>A
intron
N/A
PKD2
ENST00000506727.1
TSL:4
n.-138G>T
upstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.000112
AC:
17
AN:
151686
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00155
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000231
AC:
28
AN:
121242
AF XY:
0.000226
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00159
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000809
GnomAD4 exome
AF:
0.000107
AC:
146
AN:
1365346
Hom.:
0
Cov.:
35
AF XY:
0.000126
AC XY:
85
AN XY:
673710
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29680
American (AMR)
AF:
0.00
AC:
0
AN:
33678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24642
East Asian (EAS)
AF:
0.000648
AC:
22
AN:
33944
South Asian (SAS)
AF:
0.000817
AC:
63
AN:
77158
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33778
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5496
European-Non Finnish (NFE)
AF:
0.00000374
AC:
4
AN:
1069908
Other (OTH)
AF:
0.000999
AC:
57
AN:
57062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000988
AC:
15
AN:
151794
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74222
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41496
American (AMR)
AF:
0.00
AC:
0
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00117
AC:
6
AN:
5134
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10434
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67860
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000723
AC:
2
Asia WGS
AF:
0.0120
AC:
42
AN:
3434

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 29, 2016
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal dominant polycystic kidney disease Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PKD2-related disorder Benign:1
Feb 16, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.24
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Benign
0.30
T
Eigen
Uncertain
0.35
Eigen_PC
Uncertain
0.35
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.54
T
M_CAP
Pathogenic
0.95
D
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-0.61
T
MutationAssessor
Benign
0.81
L
PhyloP100
5.8
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-0.89
N
REVEL
Benign
0.096
Sift
Uncertain
0.0050
D
Sift4G
Uncertain
0.020
D
Polyphen
0.99
D
Vest4
0.34
MVP
0.33
MPC
0.67
ClinPred
0.10
T
GERP RS
3.5
PromoterAI
-0.040
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.29
gMVP
0.24
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371898195; hg19: chr4-88929246; API